Decentralized drug discovery platform Insilico Medicine formalized regulatory compliance pathways with United Arab Emirates agencies for AI-driven pharmaceutical protocols. The strategic partnership enables broader deployment of machine learning models across MENA region biotechnology infrastructure.

Source: South China Morning Post   Read Full Story